Epidemiology Unit, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Department of Clinical Governance, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.
PLoS One. 2020 Aug 27;15(8):e0238281. doi: 10.1371/journal.pone.0238281. eCollection 2020.
This is a population-based prospective cohort study on archive data describing the age- and sex-specific prevalence of COVID-19 and its prognostic factors. All 2653 symptomatic patients tested positive for SARS-CoV-2 from February 27 to April 2, 2020 in the Reggio Emilia province, Italy, were included. COVID-19 cumulative incidence, hospitalization and death rates, and adjusted hazard ratios (HR) with 95% confidence interval (95% CI) were calculated according to sociodemographic and clinical characteristics. Females had higher prevalence of infection than males below age 50 (2.61 vs. 1.84 ‰), but lower in older ages (16.49 vs. 20.86 ‰ over age 80). Case fatality rate reached 20.7% in cases with more than 4 weeks follow up. After adjusting for age and comorbidities, men had a higher risk of hospitalization (HR 1.4 95% CI 1.2 to 1.6) and of death (HR 1.6, 95% CI 1.2 to 2.1). Patients over age 80 compared to age < 50 had HR 7.1 (95% CI 5.4 to 9.3) and HR 27.8 (95% CI 12.5 to 61.7) for hospitalization and death, respectively. Immigrants had a higher risk of hospitalization (HR 1.3, 95% CI 0.99 to 1.81) than Italians and a similar risk of death. Risk of hospitalization and of death were higher in patients with heart failure, arrhythmia, dementia, coronary heart disease, diabetes, and hypertension, while COPD increased the risk of hospitalization (HR 1.9, 95% CI 1.4 to 2.5) but not of death (HR 1.1, 95% CI 0.7 to 1.7). Previous use of ACE inhibitors had no effect on risk of death (HR 0.97, 95% CI 0.69 to 1.34). Identified susceptible populations and fragile patients should be considered when setting priorities in public health planning and clinical decision making.
这是一项基于人群的前瞻性队列研究,对描述 COVID-19 的年龄和性别特异性患病率及其预后因素的存档数据进行了研究。所有 2653 例 2020 年 2 月 27 日至 4 月 2 日在意大利雷焦艾米利亚省检测出 SARS-CoV-2 呈阳性且有症状的患者均被纳入研究。根据社会人口统计学和临床特征,计算 COVID-19 的累积发病率、住院率和死亡率,以及调整后的风险比(HR)及其 95%置信区间(95%CI)。在年龄<50 岁的人群中,女性的感染率高于男性(2.61‰比 1.84‰),但在年龄较大的人群中(年龄>80 岁时,女性为 16.49‰,男性为 20.86‰)则低于男性。随访超过 4 周的病例病死率达到 20.7%。在调整年龄和合并症后,男性住院(HR 1.4,95%CI 1.2-1.6)和死亡(HR 1.6,95%CI 1.2-2.1)的风险更高。与年龄<50 岁的患者相比,年龄>80 岁的患者住院(HR 7.1,95%CI 5.4-9.3)和死亡(HR 27.8,95%CI 12.5-61.7)的风险更高。与意大利人相比,移民住院(HR 1.3,95%CI 0.99-1.81)和死亡(HR 1.3,95%CI 0.99-1.81)的风险更高。心力衰竭、心律失常、痴呆、冠心病、糖尿病和高血压患者的住院和死亡风险更高,而 COPD 增加了住院风险(HR 1.9,95%CI 1.4-2.5),但不增加死亡风险(HR 1.1,95%CI 0.7-1.7)。既往使用 ACE 抑制剂对死亡风险无影响(HR 0.97,95%CI 0.69-1.34)。在制定公共卫生规划和临床决策时,应考虑到这些易感人群和脆弱患者。